Bitunix to list three US-stock perpetual futures on Oct 30
Bitunix says AMGNUSDT, MELIUSDT and PFEUSDT USDT-M perpetuals open at 08:00 UTC, with leverage from 1x to 20x and parameters it may adjust.
Source-checked briefing: prepared from the official notice cited below and checked for source, date, duplication, and risk language. No individual editor review is claimed. Methodology
Bitunix announced that it will launch three USDT-M perpetual futures contracts — AMGNUSDT, MELIUSDT and PFEUSDT — at 2026-10-30 08:00 (UTC). The underlyings are Amgen Inc. (Nasdaq: AMGN), MercadoLibre, Inc. (Nasdaq: MELI) and Pfizer, Inc. (NYSE: PFE), with supported leverage of 1x to 20x for all three. The announcement does not establish any required action for users; it describes a listing and notes that Bitunix may adjust contract parameters based on market risk conditions. This content is not investment or trading advice.
On this page
- 01
Three contracts launch: AMGNUSDT, MELIUSDT and PFEUSDT, all USDT-M perpetual futures.
- 02
Launch time is 2026-10-30 08:00 (UTC), per the announcement.
- 03
Underlyings: Amgen (Nasdaq: AMGN), MercadoLibre (Nasdaq: MELI) and Pfizer (NYSE: PFE).
Key timeline
Announcement published on Bitunix support site.
Scheduled launch of AMGNUSDT, MELIUSDT and PFEUSDT perpetual futures.
Who may be affected
- Bitunix users who intend to trade USDT-M perpetual futures on the three named stock underlyings.
Impact analysis
The direct operational effect is the addition of three USDT-M perpetual contracts to Bitunix's futures lineup at a stated time, each with leverage capped at 20x at launch. Because Bitunix reserves the right to change minimum price movement, maximum leverage and margin requirements, the parameters in force at launch are not guaranteed to remain fixed. The notice does not describe order types, funding mechanics, tick sizes or contract specifications beyond leverage; those are referenced only through the Stock Perps Trading Guide and the Futures Services Agreement. Users who do not trade these contracts are not assigned any effect by the source. This content is not investment or trading advice.
What the announcement does not say
The source does not disclose contract sizes, tick sizes, funding intervals, fee schedules, margin tiers, or whether the launch time could change. It also does not state which jurisdictions or account types can access stock perpetuals.
Risk notes
- Leverage of up to 20x magnifies both gains and losses; the announcement itself carries a general crypto risk warning.
- Bitunix may adjust leverage and margin parameters at any time based on market risk conditions.
- The source does not describe how these equity-underlying perpetuals track their reference prices or handle trading-hours gaps.
- This article is for checking the exchange's official announcement only and is not investment or trading advice.
- This article verifies official exchange announcements and does not constitute investment or trading advice.
This article is for information only and is not investment, legal, or tax advice. Digital assets are volatile and may result in loss of principal.
Frequently asked questions
What exactly is launching?
Three USDT-M perpetual futures contracts: AMGNUSDT, MELIUSDT and PFEUSDT, tracking Amgen, MercadoLibre and Pfizer respectively as underlyings.
Do existing users need to do anything?
The announcement states no required action. It only gives the listing time, underlyings and leverage range.
Can the leverage or margin rules change after launch?
Yes. Bitunix says it may adjust minimum price movement, maximum leverage, initial margin and maintenance margin requirements based on market risk conditions.
Where are the full contract terms?
The announcement points to the Bitunix Futures Services Agreement and the Stock Perps Trading Guide; it does not reproduce the specifications itself.
Official sources
Collected material is used only for fact checking. If this page differs from the original announcement, the official page controls.
Follow Bitunix updates
Add this exchange-only feed to your RSS reader and receive new CoinTools analysis without an account or email.